Xeris Biopharma Holdings, Inc.

XERS

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0001875714-26-000004
Filing date: Mar 5, 2026
Earliest execution date: Mar 5, 2026
Reporting Owners: Pieper Steven (Officer)

Summary

Type

Neutral

Net shares

0

% of shares

0.00%

Amount (USD)

$0

Insider confidence score

52.5 out of 100

Positive

  • Minimal sell amount (<$10K)

Stock transactions

Transaction 1

Security

Common Stock

Action

Exercise

Date

2026-03-05

Code

M

Net shares

+27,891.0

Price per Share

$4.09

Amount (USD)

$114,074.19

Acquired/Disposed

Acquired

Shares Owned Before

1,367,013.0

Shares Owned After

1,394,904.0

Transaction 2

Security

Common Stock

Action

Exercise

Date

2026-03-05

Code

M

Net shares

+14,036.0

Price per Share

$5.93

Amount (USD)

$83,233.48

Acquired/Disposed

Acquired

Shares Owned Before

1,394,904.0

Shares Owned After

1,408,940.0

Derivative Transactions

Transaction 1

Security

Stock Option (Right to Buy)

Action

Exercise

Date

2026-03-05

Code

M

Net shares

-27,891.0

Acquired/Disposed

Disposed

Shares Owned Before

27,891.0

Shares Owned After

0.0

Transaction 2

Security

Stock Option (Right to Buy)

Action

Exercise

Date

2026-03-05

Code

M

Net shares

-14,036.0

Acquired/Disposed

Disposed

Shares Owned Before

14,036.0

Shares Owned After

0.0

Filing's footnotes

1. The reporting person received the stock options on December 10, 2020 pursuant to an award under the Company's 2018 Stock Option/Stock Issuance Plan. 50% of the options vested on the firstanniversary of the vesting commencement date, and the remaining 50% of options vested on the second anniversary of the vesting commencement date, in each case subject to continued employment through such vesting date.

2. The reporting person received the stock options on January 31, 2018 pursuant to an award under the Company's 2011 Stock Option/Stock Issuance Plan. 25% of the options vested on the firstanniversary of the vesting commencement date, and the remaining 75% of options vested in equal monthly installments over the following three (3) years, in each case subject to continued employment through suchvesting date.

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.